
<!DOCTYPE html>
<!--[if lt IE 8]>      <html class="no-js nav theme-blue lt-ie10 lt-ie9 lt-ie8  " lang="en-us"> <![endif]-->
<!--[if IE 8]>         <html class="no-js nav theme-blue lt-ie10 lt-ie9  " lang="en-us"> <![endif]-->
<!--[if IE 9]>         <html class="no-js nav theme-blue lt-ie10  " lang="en-us"> <![endif]-->
<!--[if !IE]><!-->     <html class="no-js nav theme-blue  " lang="en-us" > <!--<![endif]-->	
    <head>
        <meta charset="utf-8" />
                		<title>Trichomoniasis - 2015 STD Treatment Guidelines</title>
        		
        <meta name="description" content="Trichomoniasis - 2015 STD Treatment Guidelines" />        <meta name="keywords" content="2015, treatment guidelines, treatment, STD, sexually transmitted diseases, trichomoniasis, STI, CDC" />		<meta name="viewport" content="width=device-width, initial-scale=1" />
		        <link rel="apple-touch-icon-precomposed" sizes="144x144" href="../../TemplatePackage/3.0/images/cdc-touch-icon-144x144.png" />
        <link rel="apple-touch-icon-precomposed" sizes="114x114" href="../../TemplatePackage/3.0/images/cdc-touch-icon-114x114.png" />
        <link rel="apple-touch-icon-precomposed" sizes="72x72" href="../../TemplatePackage/3.0/images/cdc-touch-icon-72x72.png" />
        <link rel="apple-touch-icon-precomposed" href="../../TemplatePackage/3.0/images/cdc-touch-icon-57x57.png" />
        <link rel="shortcut icon" href="../../TemplatePackage/3.0/images/favicon.ico" />	
		
		<meta name="robots" content="index,follow" />
		<meta property="cdc:template_version" content="3.0" />
		<meta property="cdc:content-id" content="709562"/>
		<meta property="cdc:revision-id" content="3"/>
				<link rel="canonical" href="http://www.cdc.gov/std/tg2015/trichomoniasis.htm"/>
				<!-- Internal Release Version # 3.7 -->
                			<link rel="stylesheet" href="../../TemplatePackage/3.0/css/lib/bootstrap24.css" />
	<link rel="stylesheet" href="../../TemplatePackage/3.0/css/app.css@3.2.1.7.css" />
	<!--[if gt IE 9]><!--><!--<![endif]-->
	<!--[if IE 7]>
		<link rel="stylesheet" href="/TemplatePackage/3.0/css/lib/font-awesome-ie7.css" />
	<![endif]-->
	<!--[if lt IE 9]>
		<link rel="stylesheet" href="/TemplatePackage/3.0/css/ie.css" />
	<![endif]-->
	<link rel="stylesheet" media="print" href="../../TemplatePackage/3.0/css/print.css@3.2.1.7.css" />
	<script src="../../TemplatePackage/3.0/js/libs/modernizr-latest.js"></script>
	<script>
		if(!Date.now){Date.now=function now(){return new Date().getTime()}}
		var page_timing = page_timing || {};
		page_timing.page_start = Date.now();
		function $$(e){if(window.$){e()}else{setTimeout(function(){$$(e)},50)}}
		// (function(){function e(e,t){var n=e.length;while(n--){if(e[n].indexOf(t)>-1){return e[n]}}return false}var t=e(document.getElementsByTagName("html")[0].className.split(" "),"theme-");if(t){var n=document.createElement("link");n.rel="stylesheet";n.type="text/css";n.media="screen";n.href="/TemplatePackage/3.0/css/themes/"+t+".css";document.getElementsByTagName("head")[0].appendChild(n)}})();

		var settings = {}, addthis = null;
	</script>

	<meta name="application-name" content="CDC.gov"/>
	<meta property="cdc:template_version" content="3.2.1.7" />
	<meta name="msapplication-TileColor" content="#0061aa" />
	<meta name="msapplication-square70x70logo" content="/TemplatePackage/3.0/images/Win8_tile_70x70.png" />
	<meta name="msapplication-square150x150logo" content="/TemplatePackage/3.0/images/Win8_tile_150x150.png" />
	<meta name="msapplication-wide310x150logo" content="/TemplatePackage/3.0/images/Win8_tile_310x150.png" />
	<meta name="msapplication-square310x310logo" content="/TemplatePackage/3.0/images/Win8_tile_310x310.png" />
	<meta name="viewport" content="width=device-width,initial-scale=1,shrink-to-fit=no">		        



                		    </head>
    <body>
				



				<div id="skipmenu">
	<a href="trichomoniasis.htm#searchTarget" class="skippy">Skip directly to search</a>
	<a href="trichomoniasis.htm#azTab" class="skippy">Skip directly to A to Z list</a>
	<a href="trichomoniasis.htm#nav-container" class="skippy">Skip directly to navigation</a>
	<a href="trichomoniasis.htm#share-bar" class="skippy">Skip directly to page options</a>
	<a href="trichomoniasis.htm#contentArea" class="skippy">Skip directly to site content</a>
</div>		    	<div id="wrapper">
    		
<!-- references to this removed intentionally -->
    		<header id="header">
    			<div class="container">
                    <div class="row">
                    	<div id="logo" class="span14">
                    		<!--iPad touch response and 508 voice reader issue currently under investigation -->
<a href="../../index.html" title="Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People">
	<img src="../../TemplatePackage/3.0/images/masthead_subpage.svg" alt="Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People" class="hidden-one" />
	<img src="../../TemplatePackage/3.0/images/masthead_1-col.svg" alt="Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People" class="visible-one" />
</a>

<!-- IOS9 iPad bug work around - make sure screen readers have a readable version of the logo to read
<a class="tp-sr-only" href="https://www.cdc.gov">Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People</a>
 -->
                    	</div>
                    	<!-- search -->
                    	<div id="searchArea" class="span10 hidden-one hidden-two">							
							
<div class="hidden"><a href="trichomoniasis.htm#" name="searchTarget">Start of Search Controls</a></div>
<form class="searchForm" method="get" action="https://search.cdc.gov/search">
	<fieldset class="search-form-wrapper ">
		<legend>Search Form Controls</legend>
		<div class="search-form-checkbox">
			<label class="subset"><input type="checkbox" name="subset" checked="checked" value="">Search The CDC</label>
		</div>
		<div class="search-input-wrapper">
			<div class="search-buttons">
				<button class="btn-clear"><span class="sprite-14-close">Cancel</span></button>
				<button class="btn-submit"><span class="sprite-14-search-black">Submit</span></button>
				<input type="submit" value="Submit" style="display:none; visibility:hidden;" /> 
			</div>
			<div class="search-input">
				<label><input type="text" placeholder="SEARCH" name="query" /><span class="hidden">Search The CDC</span></label>
			</div>
		</div>
		<input type="hidden" name="utf8" value="&#x2713;" />
					<input type="hidden" name="affiliate" value="cdc-main" />
			</fieldset>
</form>							<div class="a2z-button pull-right hidden-one hidden-two"><a href="trichomoniasis.htm#" id="azTab">CDC A-Z Index <span class="icon-angle-down"></span></a></div>
                    	</div>
                    </div>
                    	<div class="hidden-three hidden-four" id="mobile-menu">
		<ul>
			<li id="vp1-menu-button" class="border-bottom-white"><a href="trichomoniasis.htm#" id="menu-nav"><span class="sprite-16-menu"></span>MENU</a></li>
			<li id="vp1-a2z-button" class="border-bottom-white"><a href="trichomoniasis.htm#" id="menu-az">CDC A-Z</a></li>
			<li id="vp1-search-button" class="border-bottom-white"><a href="trichomoniasis.htm#" id="menu-search"><span class="sprite-16-search-white"></span>SEARCH</a></li>
		</ul>
	</div>
<script>if (typeof page_timing !== 'undefined') { page_timing.menu_load = Date.now(); }</script>
                    <div class="a2z-bar hide">
                    	<div>
	<ul>
		<li><a href="../../az/a.html">A</a></li>
		<li><a href="../../az/b.html">B</a></li>
		<li><a href="../../az/c.html">C</a></li>
		<li><a href="../../az/d.html">D</a></li>
		<li><a href="../../az/e.html">E</a></li>
		<li><a href="../../az/f.html">F</a></li>
		<li><a href="../../az/g.html">G</a></li>
		<li><a href="../../az/h.html">H</a></li>
		<li><a href="../../az/i.html">I</a></li>
		<li><a href="../../az/j.html">J</a></li>
		<li><a href="../../az/k.html">K</a></li>
		<li><a href="../../az/l.html">L</a></li>
		<li><a href="../../az/m.html">M</a></li>
		<li><a href="../../az/n.html">N</a></li>
		<li><a href="../../az/o.html">O</a></li>
		<li><a href="../../az/p.html">P</a></li>
		<li><a href="../../az/q.html">Q</a></li>
		<li><a href="../../az/r.html">R</a></li>
		<li><a href="../../az/s.html">S</a></li>
		<li><a href="../../az/t.html">T</a></li>
		<li><a href="../../az/u.html">U</a></li>
		<li><a href="../../az/v.html">V</a></li>
		<li><a href="../../az/w.html">W</a></li>
		<li><a href="../../az/x.html">X</a></li>
		<li><a href="../../az/y.html">Y</a></li>
		<li><a href="../../az/z.html">Z</a></li>
		<li><a href="../../az/0.html">#</a></li>
	</ul>
</div>
<script>if (typeof page_timing !== 'undefined') { page_timing.a2z_load = Date.now(); }</script>                    </div>
                    <div id="searchArea-two-column" class="span24 searchbar hide hidden-three hidden-four">
						  
<div class="hidden"><a href="trichomoniasis.htm#" name="searchTarget">Start of Search Controls</a></div>
<form class="searchForm" method="get" action="https://search.cdc.gov/search">
	<fieldset class="search-form-wrapper ">
		<legend>Search Form Controls</legend>
		<div class="search-form-checkbox">
			<label class="subset"><input type="checkbox" name="subset" checked="checked" value="">Search The CDC</label>
		</div>
		<div class="search-input-wrapper">
			<div class="search-buttons">
				<button class="btn-clear"><span class="sprite-14-close">Cancel</span></button>
				<button class="btn-submit"><span class="sprite-14-search-black">Submit</span></button>
				<input type="submit" value="Submit" style="display:none; visibility:hidden;" /> 
			</div>
			<div class="search-input">
				<label><input type="text" placeholder="SEARCH" name="query" /><span class="hidden">Search The CDC</span></label>
			</div>
		</div>
		<input type="hidden" name="utf8" value="&#x2713;" />
					<input type="hidden" name="affiliate" value="cdc-main" />
			</fieldset>
</form>					</div>
                    <!--
	See the noscript include for modifying the emergency message. DO NOT add it here.
-->
<script>if (typeof page_timing !== 'undefined') { page_timing.emergency_load = Date.now(); }</script>
    				<div class="titlebar">
					 						<h2>


<a href="default.htm">2015 Sexually Transmitted Diseases Treatment Guidelines</a>

</h2>
					 					</div>
    				<!-- emergency -->
<div id="emergencyContainer">
	<!--
	<div class="alert alert-error en">
		<b>Attention!</b> Uncomment this section and place the emergency message here.
	</div>
	<div class="alert alert-error esp">
		<b>&#161;Atenci&#243;n!</b> Elimine el comentario de esta secci&#243;n y colocar el mensaje de emergencia aqu&#237;.
	</div>	
	-->
</div>

<!-- no script -->
<noscript>
	<div class="alert alert-block"> Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: <a href="../../other/about_cdcgov.html">About CDC.gov</a>.</div>
</noscript>
<script>if (typeof page_timing !== 'undefined') { page_timing.noscript_load = Date.now(); }</script>
     			</div>
    		</header>
    		<div class="container">				
                <div id="content">
					<div class="row">
        				<!-- left nav -->
        				<div id="nav-container" class="hidden-one hidden-two span5">
    						<nav id="left" class="hidden-one hidden-two">
    							



<h3><a href="default.htm">2015 STD Treatment Guidelines</a></h3>

<ul id="nav-primary">
<li><a href="https://www.cdc.gov/std/tg2015/toc.htm">Table of Contents</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/intro.htm">Introduction and Methods</a></li>

<li><a href="clinical.htm">Clinical Prevention Guidance</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/specialpops.htm">Special Populations</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/emerging.htm">Emerging Issues</a></li>

<li><a href="hiv.htm">HIV Infection: Detection,Counseling and Referral</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/genital-ulcers.htm">Diseases Characterized by Genital, Anal, or Perianal Ulcers</a>
<ul>
<li><a href="https://www.cdc.gov/std/tg2015/chancroid.htm">Chancroid</a></li>

<li><a href="herpes.htm">Genital HSV Infections</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/donovanosis.htm">Granuloma Inguinale (Donovanosis)</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/lgv.htm">Lymphogranuloma Venereum (LGV)</a></li>
</ul>
</li>

<li><a href="https://www.cdc.gov/std/tg2015/syphilis.htm">Syphilis</a>
<ul>
<li><a href="https://www.cdc.gov/std/tg2015/syphilis-pregnancy.htm">Syphilis During Pregnancy</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/congenital.htm">Congenital Syphilis</a></li>
</ul>
</li>

<li><a href="https://www.cdc.gov/std/tg2015/pen-allergy.htm">Management of Persons Who Have a History of Penicillin Allergy</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/urethritis-and-cervicitis.htm">Diseases Characterized by Urethritis and Cervicitis</a></li>

<li><a href="chlamydia.htm">Chlamydial Infections</a></li>

<li><a href="gonorrhea.htm">Gonococcal Infections</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/vaginal-discharge.htm">Diseases Characterized by Vaginal Discharge</a>
<ul id="nav-primary">
<li><a href="bv.htm">Bacterial Vaginosis</a></li>

<li><a href="trichomoniasis.htm">Trichomoniasis</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/candidiasis.htm">Vulvovaginal Candidiasis</a></li>
</ul>
</li>

<li><a href="https://www.cdc.gov/std/tg2015/pid.htm">Pelvic Inflammatory Disease (PID)</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/epididymitis.htm">Epididymitis</a></li>

<li><a href="hpv.htm">Human Papillomavirus (HPV) Infection</a></li>

<li><a href="warts.htm">Anogenital Warts</a></li>

<li><a href="hpv-cancer.htm">HPV-Associated Cancers and Precancers</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/hepatitis.htm">Viral Hepatitis</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/proctitis.htm">Proctitis, Proctocolitis, and Enteritis</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/ectoparasitic.htm">Ectoparasitic Infections</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/sexual-assault.htm">Sexual Assault and Abuse and STDs</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/references.htm">References</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/terms.htm">Terms and Abbreviations Used in This Report</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/consultants.htm">Consultants</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/evidence.htm">Evidence Tables</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/screening-recommendations.htm">Screening Recommendations Referenced in Treatment Guidelines and Original Recommendation Sources</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/default.htm">Questions and Answers</a>
<ul id="nav-primary">
<li><a href="https://www.cdc.gov/std/tg2015/qa/bv-qa.htm">Bacterial Vaginosis (BV)</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/chlamydia-qa.htm">Chlamydia</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/gonorrhea-qa.htm">Gonorrhea</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/herpes-qa.htm">Herpes</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/hpv-qa.htm">HPV</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/mycoplasma-genitaliumqa.htm"><em>Mycoplasma genitalium</em></a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/screening-qa.htm">Screening</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/sexual-assault-qa.htm">Sexual Assault</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/syphilis-qa.htm">Syphilis</a></li>

<li><a href="https://www.cdc.gov/std/tg2015/qa/trichomoniasis-qa.htm">Trichomoniasis</a></li>
</ul>
</li>
</ul>


    						</nav>
    						<div class="nav-related">
							



    						



<div class="module-typeH">
<h3><a href="../default.htm">STDs Home Page</a></h3>

<ul class="list-block">
<li><a href="../treatment/default.htm">Treatment</a></li>
</ul>
</div>

<div class="module-typeH">
<h3>Follow STD</h3>

<ul class="list-block">
<li><a href="https://twitter.com/CDCSTD"><span class="sprite-32-twitter"><!-- marker --></span>STD on Twitter</a></li>

<li style=" text-align: left;"><a href="https://www.facebook.com/CDCSTD"><span class="sprite-32-facebook"><!-- marker --></span>STD on Facebook</a></li>
</ul>
</div>


							



							</div>    						    				
        				</div>
        				<div id="featureArea">
    						<div class="span19">
    							



    						</div>
        				</div>						
    					<div class="breadcrumbs hidden-one span19">
    						


<div class="bread-crumb hidden-one"><div class="prefix"><span><a href="../treatment/default.htm">Treatment</a></span> <span><a href="../default.htm">Sexually Transmitted Diseases</a></span></div></div>

    					</div>
						<div class="span19 pagetitle">	
    						    						    							<div class='mSyndicate'>
    																					<h1>Trichomoniasis</h1>
															    						    						    							</div>
    												</div>
						<div id="share-bar" class="span19">		
    						<div class="socialmediabar">
								<div class="row">
            						<div class="hidden-one pull-right">
        								            							            							            						</div>	
    								<div class="span8">
    									<div id="socialMediaShareContainer">
	<div class="share_container noLinking">
	 	<a class="share_button_facebook" title="Facebook" href="trichomoniasis.htm#"><span class="tp-sr-only">Recommend on Facebook</span><span id="share_facebook" class="facebookRecommend"> </span></a>
	 	<a class="share_button_twitter" title="Twitter" href="trichomoniasis.htm#"><span class="tp-sr-only">Tweet</span><span id="share_twitter" class="twitterTweet"> </span></a>
		<a class="share_button" href="trichomoniasis.htm#socialMediaShareContainer" ><img src="../../TemplatePackage/3.0/images/social/addthis-32.png" alt="Share" /><span class="shareButtonEn tp-sr-only" aria-label="Share">Share</span><span class="shareButtonEs tp-sr-only" aria-label="Compartir">Compartir</span></a>
	</div>
</div>

<!-- target anchor for return to top feature in VP1 -->
<a id="content-start" tabindex="-1"></a>
    								</div>
								</div>
    						</div>
    					</div>	
    					<!-- body -->
    					<div id="body" class="span19">
    						<div id="contentArea" >								
        						        																						        						                                                                                            					            					            						<div class='mSyndicate'>
            					            					        							
<p>Trichomoniasis is the most prevalent nonviral sexually transmitted infection in the United States, affecting an estimated 3.7 million persons (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#533">533</a></em>). Health disparities persist in the epidemiology of <em>T. vaginalis</em> infection in the United States: 13% of black women are affected compared with 1.8% of non-Hispanic white women <em>(<a href="https://www.cdc.gov/std/tg2015/references.htm#639">639</a>)</em>. <em>T. vaginalis</em> infection affects &#62;11% of women aged ≥40 years (<em>640</em>), and particularly high prevalence has been detected among STD clinic patients (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#641">641</a></em>) (26% of symptomatic women and 6.5% asymptomatic women tested) and incarcerated persons (9%–32% of incarcerated women [<em><a href="https://www.cdc.gov/std/tg2015/references.htm#135">135,136</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#640">640</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#642">642,643</a></em>] and 2%–9% of incarcerated men) (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#136">136,137</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#644">644,645</a></em>). The prevalence of trichomoniasis in MSM is low (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#646">646,647</a></em>).</p>

<p>Some infected men have symptoms of urethritis, epididymitis, or prostatitis, and some infected women have vaginal discharge that might be diffuse, malodorous, or yellow-green with or without vulvar irritation. However, most infected persons (70%–85%) have minimal or no symptoms, and untreated infections might last for months to years (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#86">86</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#639">639</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#648">648</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#649">649</a></em>). Although partners might be unaware of their infection, it is readily passed between sex partners during penile-vaginal sex (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#650">650</a></em>). Among persons who are sexually active, the best way to prevent trichomoniasis is through consistent and correct use of condoms during all penile-vaginal sexual encounters (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#22">22</a></em>). Partners of men who have been circumcised might have a somewhat reduced risk of <em>T. vaginalis</em> infection (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#56">56</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#651">651</a></em>). Douching is not recommended because it might increase the risk for vaginal infections, including trichomoniasis (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#652">652</a></em>).</p>

<p><em>T. vaginalis</em> infection is associated with two- to threefold increased risk for HIV acquisition (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#653">653-656</a></em>), preterm birth, and other adverse pregnancy outcomes among pregnant women. Among women with HIV infection, <em>T. vaginalis</em> infection is associated with increased risk for PID (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#657">657-659</a></em>). Routine screening of asymptomatic women with HIV infection for <em>T. vaginalis</em> is recommended because of the adverse events associated with asymptomatic trichomoniasis and HIV infection.</p>

<p>Diagnostic testing for <em>T. vaginalis</em> should be performed in women seeking care for vaginal discharge. Screening&#160;might be considered for persons receiving care in high-prevalence settings (e.g., STD clinics and correctional facilities) and for asymptomatic persons at high risk for infection (e.g., persons with multiple sex partners, exchanging sex for payment, illicit drug use, or a history of STD). However, data are lacking on whether screening and treatment for asymptomatic trichomoniasis in high prevalence settings or persons at high risk can reduce any adverse health events and health disparities or reduce community burden of infection. Decisions about screening might be informed by local epidemiology of <em>T. vaginalis</em> infection.</p>

<p>Whether the rectum can be a reservoir for <em>T. vaginalis</em> infection is unclear; data are needed to clarify whether this occasional finding might reflect recent depositing contamination in up to 5% of persons reporting recent receptive anal sex (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#660">660,661</a></em>). Further, the efficacy, benefit, and cost-effectiveness of rectal screening are unknown; therefore, rectal testing for <em>T. vaginalis</em> is not recommended. Similarly, oral testing for <em>T. vaginalis</em> is not recommended because of a lack of evidence for oral infections. <em>T. vaginalis</em> infection is not a nationally notifiable condition in the United States (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#118">118</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#662">662</a></em>).</p>

<h3><a id="diag"> </a>Diagnostic Considerations</h3>

<p>The use of highly sensitive and specific tests is recommended for detecting <em>T. vaginalis.</em> Among women, NAAT is highly sensitive, often detecting three to five times more <em>T. vaginalis</em> infections than wet-mount microscopy, a method with poor sensitivity (51%–65%) (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#663">663,664</a></em>). The APTIMA <em>T. vaginalis</em> assay (Hologic Gen-Probe, San Diego, CA) is FDA-cleared for detection of <em>T. vaginalis</em> from vaginal, endocervical, or urine specimens from women. This assay detects RNA by transcription-mediated amplification with a clinical sensitivity of 95.3%–100% and specificity of 95.2%–100% (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#665">665,666</a></em>). Among women, vaginal swab and urine have up to 100% concordance (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#663">663</a></em>). As analyte-specific reagents, this assay can be used with urine or urethral swabs from men if validated per CLIA regulations. The sale, distribution, and use of analyte-specific reagents are allowed under 21 C.F.R. 809.30 pertaining to in vitro diagnostic products for human use. For <em>T. vaginalis</em> diagnosis in men, the sensitivity of self-collected penile-meatal swabs was higher than that of urine in one study (80% and 39%, respectively) (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#667">667</a></em>). The BD Probe Tec TV Q<sup>x</sup> Amplified DNA Assay (Becton Dickinson, Franklin Lakes, New Jersey) is FDA-cleared for detection of <em>T. vaginalis</em> from endocervical, vaginal, or urine specimens from women. Although it might be feasible to perform these tests on the same specimen used for chlamydia and gonorrhea screening, the epidemiology of trichomoniasis is distinct and should not be overlooked in older adults.</p>

<p>Other FDA-cleared tests to detect <em>T. vaginalis</em> in vaginal secretions include the OSOM Trichomonas Rapid Test (Sekisui Diagnostics, Framingham, MA), an antigen-detection test using immunochromatographic capillary flow dipstick technology that can be performed at the point of care, and the Affirm VP III (Becton Dickinson, Sparks, MD), a DNA hybridization probe test that evaluates for <em>T. vaginalis</em>, <em>G. vaginalis</em>, and <em>Candida albicans</em>. The results of the OSOM Trichomonas Rapid Test are available in approximately 10 minutes, with sensitivity 82%–95% and specificity 97%–100% (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#666">666</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#668">668</a></em>). Self-testing might become an option, as a study of 209 young women aged 14–22 years found that &#62;99% could correctly perform and interpret her own self-test using the OSOM assay, with a high correlation with clinician interpretation (96% agreement, κ&#160;=&#160;0.87) (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#669">669</a></em>). The results of the Affirm VP III are available within 45 minutes. Sensitivity and specificity are 63% and 99.9%, respectively, compared with culture and TMA; sensitivity might be higher among women who are symptomatic (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#670">670,671</a></em>). Neither the OSOM nor the Affirm VP III test is FDA-cleared for use with specimens obtained from men.</p>

<p>Culture was considered the gold standard method for diagnosing <em>T. vaginalis</em> infection before molecular detection methods became available. Culture has a sensitivity of 75%–96% and a specificity of up to 100% (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#475">475</a></em>). In women, vaginal secretions are the preferred specimen type for culture, as urine culture is less sensitive (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#475">475</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#672">672,673</a></em>). In men, culture specimens require a urethral swab, urine sediment, and/or semen. To improve yield, multiple specimens from men can be used to inoculate a single culture.</p>

<p>The most common method for <em>T. vaginalis</em> diagnosis might be microscopic evaluation of wet preparations of genital secretions because of convenience and relatively low cost. Unfortunately, the sensitivity of wet mount is low (51%–65%) in vaginal specimens (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#475">475</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#666">666</a></em>) and lower in specimens from men (e.g., urethral specimens, urine sediment, and semen). Clinicians using wet mounts should attempt to evaluate slides immediately because sensitivity declines as evaluation is delayed, decreasing by up to 20% within 1 hour after collection (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#674">674</a></em><a href="https://www.cdc.gov/std/tg2015/references.htm#674">,</a> <em><a href="https://www.cdc.gov/std/tg2015/references.htm#674">675</a></em>). When highly sensitive (e.g., NAAT) testing on specimens is not feasible, a testing algorithm (e.g., wet mount first, followed by NAAT if negative) can improve diagnostic sensitivity in persons with an initial negative result by wet mount (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#475">475</a></em>). Although <em>T. vaginalis</em> may be an incidental finding on a Pap test, neither conventional nor liquid-based Pap tests are considered diagnostic tests for trichomoniasis, because false negatives and false positives can occur.</p>

<h3>Treatment</h3>

<p>Treatment reduces symptoms and signs of <em>T. vaginalis</em> infection and might reduce transmission. Likelihood of adverse outcomes in women with HIV also is reduced with <em>T. vaginalis</em> therapy.&#160;</p>

<div class="module-typeF">
<h5><em>Recommended Regimen</em></h5>

<ul class="list-block">
<li><strong>Metronidazole</strong> 2 g orally in a single dose<br />
OR</li>

<li><strong>Tinidazole</strong> 2 g orally in a single dose</li>
</ul>

<h5><em>Alternative Regimen</em>&#160;</h5>

<ul class="list-block">
<li><strong>Metronidazole</strong>&#160;500 mg orally twice a day for 7 days</li>
</ul>
</div>

<p>Alcohol consumption should be avoided during treatment with nitroimidazoles. To reduce the possibility of a disulfiram-like reaction, abstinence from alcohol use should continue for 24 hours after completion of metronidazole or 72 hours after completion of tinidazole.</p>

<p>The nitroimidazoles are the only class of antimicrobial medications known to be effective against <em>T. vaginalis</em> infections. Of these drugs, metronidazole and tinidazole have been cleared by FDA for the oral or parenteral treatment of trichomoniasis. Tinidazole is generally more expensive, reaches higher levels in serum and the genitourinary tract, has a longer half-life than metronidazole (12.5 hours versus 7.3 hours), and has fewer gastrointestinal side effects (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#676">676-678</a></em>). In randomized clinical trials, recommended metronidazole regimens have resulted in cure rates of approximately 84%–98% (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#679">679-681</a></em>), and the recommended tinidazole regimen has resulted in cure rates of approximately 92%–100% (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#680">680</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#682">682-685</a></em>). Randomized controlled trials comparing single 2 g doses of metronidazole and tinidazole suggest that tinidazole is equivalent or superior to metronidazole in achieving parasitologic cure and resolution of symptoms (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#686">686</a></em>).</p>

<p>Metronidazole gel does not reach therapeutic levels in the urethra and perivaginal glands. Because it is less efficacious than oral metronidazole, it is not recommended.</p>

<h3>Other Management Considerations</h3>

<p>Providers should advise persons infected with <em>T. vaginalis</em> to abstain from sex until they and their sex partners are treated (i.e., when therapy has been completed and any symptoms have resolved). Testing for other STDs including HIV should be performed in persons infected with <em>T vaginalis</em>.</p>

<h3>Follow-up</h3>

<p>Because of the high rate of reinfection among women treated for trichomoniasis (17% within 3 months in one study) (<em>86</em>), retesting for <em>T. vaginalis</em> is recommended for all sexually active women within 3 months following initial treatment regardless of whether they believe their sex partners were treated (see <a href="trichomoniasis.htm#diag">Diagnostic Considerations</a>). Testing by nucleic acid amplification can be conducted as soon as 2 weeks after treatment (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#687">687,688</a></em>)<em>.</em> Data are insufficient to support retesting men.</p>

<h3>Management of Sex Partners</h3>

<p>Concurrent treatment of all sex partners is critical for symptomatic relief, microbiologic cure, and prevention of transmission and reinfections. Current partners should be referred for presumptive therapy to avoid reinfection. Partners should be advised to abstain from intercourse until they and their sex partners have been adequately treated and any symptoms have resolved. EPT might have a role in partner management for trichomoniasis (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#97">97,98</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#689">689</a></em>) and can be used in states where permissible by law; however, no one partner management intervention has been shown to be superior in reducing reinfection rates. Though no definitive data exist to guide treatment for partners of persons with persistent or recurrent trichomoniasis in whom nonadherance and reinfection are unlikely, partners benefit from undergoing evaluation and receiving the same regimen as the patient (see Persistent or Recurrent Trichomoniasis).</p>

<h3>Persistent or Recurrent Trichomoniasis</h3>

<p>Persistent or recurrent infection caused by antimicrobial-resistant <em>T. vaginalis</em> or other causes should be distinguished from the possibility of reinfection from an untreated sex partner. Although most recurrent <em>T. vaginalis</em> infections are thought to result from reinfection, some infections might be attributed to antimicrobial resistance. Metronidazole resistance occurs in 4%–10% of cases of vaginal trichomoniasis (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#690">690,691</a></em>), and tinidazole resistance in 1% (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#691">691</a></em>). In general, <em>T. vaginalis</em> isolates have lower minimum lethal concentrations to tinidazole than metronidazole (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#692">692</a></em>). Emerging nitroimidazole-resistant trichomoniasis is concerning, because few alternatives to standard therapy exist. Single-dose therapy should be avoided for treating recurrent trichomoniasis that is not likely a result of reinfection. If treatment failure has occurred with metronidazole 2 g single dose and reinfection is excluded, the patient (and their partner[s]) can be treated with metronidazole 500 mg orally twice daily for 7 days. If this regimen fails, clinicians should consider treatment with metronidazole or tinidazole at 2 g orally for 7 days. If several 1-week regimens have failed in a person who is unlikely to have nonadherence or reinfection, testing of the organism for metronidazole and tinidazole susceptibility is recommended (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#693">693</a></em>). CDC has experience with susceptibility testing for nitroimidazole-resistant <em>T. vaginalis</em> and treatment management of infected persons and can provide assistance (telephone: 404–718–4141; website:<a href="https://www.cdc.gov/laboratory/specimen-submission/detail.html?CDCTestCode=CDC-10239"> https://www.cdc.gov/laboratory/specimen-submission/detail.html?CDCTestCode=CDC-10239</a>). Higher dose tinidazole at 2–3g for 14 days, often in combination with intravaginal tinidazole, can be considered in cases of nitroimidazole-resistant infections; however, such cases should be managed in consultation with an expert.</p>

<p>Alternative regimens might be effective but have not been systematically evaluated; therefore, consultation with an infectious-disease specialist is recommended. The most anecdotal experience has been with intravaginal paromomycin in combination with high-dose tinidazole (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#694">694-696</a></em>); clinical improvement has been reported with other alternative regimens including intravaginal boric acid (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#697">697,698</a></em>) and nitazoxanide (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#699">699</a></em>). The following topically applied agents have shown minimal success (&#60;50%) and are not recommended: intravaginal betadine (povidone-iodine), clotrimazole, acetic acid, furazolidone, gentian violet, nonoxynol-9, and potassium permanganate (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#700">700</a></em>). No other topical microbicide has been shown to be effective against trichomoniasis (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#701">701</a></em>).</p>

<h3>Special Considerations</h3>

<h4>Allergy, Intolerance, and Adverse Reactions</h4>

<p>Metronidazole and tinidazole are both nitroimidazoles. Patients with an IgE mediated-type allergy to a nitroimidazole can be managed by metronidazole desensitization according to a published regimen (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#702">702</a></em>) and in consultation with a specialist.</p>

<h4><a id="preg"> </a>Pregnancy</h4>

<p><em>T. vaginalis</em> infection in pregnant women is associated with adverse pregnancy outcomes, particularly premature rupture of membranes, preterm delivery, and delivery of a low birthweight infant (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#658">658</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#703">703-705</a></em>). Although metronidazole treatment produces parasitologic cure, certain trials have shown no significant difference in perinatal morbidity following metronidazole treatment. One trial suggested the possibility of increased preterm delivery in women with <em>T. vaginalis</em> infection who received metronidazole treatment (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#706">706</a></em>), yet study limitations prevented definitive conclusions regarding the risks of treatment. More recent, larger studies have shown no positive or negative association between metronidazole use during pregnancy and adverse outcomes of pregnancy (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#634">634</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#707">707-710</a></em>). If treatment is considered, the recommended regimen in pregnant women is metronidazole 2 g orally in a single dose. Symptomatic pregnant women, regardless of pregnancy stage, should be tested and considered for treatment. Treatment of <em>T. vaginalis</em> infection can relieve symptoms of vaginal discharge in pregnant women and reduce sexual transmission to partners. Although perinatal transmission of trichomoniasis is uncommon, treatment also might prevent respiratory or genital infection of the newborn (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#711">711,712</a></em>). Clinicians should counsel symptomatic pregnant women with trichomoniasis regarding the potential risks for and benefits of treatment and about the importance of partner treatment and condom use in the prevention of sexual transmission.</p>

<p>The benefit of routine screening for <em>T. vaginalis</em> in asymptomatic pregnant women has not been established. However, screening at the first prenatal visit and prompt treatment, as appropriate, are recommended for pregnant women with HIV infection, because <em>T. vaginalis</em> infection is a risk factor for vertical transmission of HIV (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#713">713</a></em>). Pregnant women with HIV who are treated for <em>T. vaginalis</em> infection should be retested 3 months after treatment.</p>

<p>Although metronidazole crosses the placenta, data suggest that it poses a low risk to pregnant women (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#317">317</a></em>). No evidence of teratogenicity or mutagenic effects in infants has been found in multiple cross-sectional and cohort studies of pregnant women (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#708">708-710</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#714">714</a></em>). Women can be treated with 2 g metronidazole in a single dose at any stage of pregnancy.</p>

<p>Metronidazole is secreted in breast milk. With maternal oral therapy, breastfed infants receive metronidazole in doses that are lower than those used to treat infections in infants, although the active metabolite adds to the total infant exposure. Plasma levels of the drug and metabolite are measurable, but remain less than maternal plasma levels (<a href="http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT">http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT</a>). Although several reported case series found no evidence of adverse effects in infants exposed to metronidazole in breast milk, some clinicians advise deferring breastfeeding for 12–24 hours following maternal treatment with a single 2-g dose of metronidazole (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#635">635</a></em>). Maternal treatment with metronidazole (400 mg three times daily for 7 days) produced a lower concentration in breast milk and was considered compatible with breastfeeding over longer periods of time (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#636">636,637</a></em>).</p>

<p>Data from studies involving human subjects are limited regarding use of tinidazole in pregnancy; however, animal data suggest this drug poses moderate risk. Thus, tinidazole should be avoided in pregnant women, and breastfeeding should be deferred for 72 hours following a single 2-g dose of tinidazole (http://toxnet.nlm.nih.gov/newtoxnet/lactmed.htm).</p>

<h4><a id="hiv"> </a>HIV Infection</h4>

<p>Up to 53% of women with HIV infection also are infected with <em>T. vaginalis (<a href="https://www.cdc.gov/std/tg2015/references.htm#715">715,716</a>). T. vaginalis</em> infection in these women is significantly associated with PID (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#659">659</a></em>), and treatment of trichomoniasis is associated with significant decreases in genital-tract HIV viral load and viral shedding (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#717">717,718</a></em>). For these reasons, routine screening and prompt treatment are recommended for all women with HIV infection; screening should occur at entry to care and then at least annually thereafter. A randomized clinical trial involving women with HIV infection and <em>T. vaginalis</em> infection demonstrated that a single dose of metronidazole 2 g orally was less effective than 500 mg twice daily for 7 days (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#719">719</a></em>). Thus, to improve cure rates, women with HIV infection who receive a diagnosis of <em>T. vaginalis</em> infection should be treated with metronidazole 500 mg orally twice daily for 7 days (rather than with a 2-g single dose of metronidazole). Factors that might interfere with standard single-dose treatment for trichomoniasis in these women include high rates of asymptomatic BV co-infections, use of antiretroviral therapy, changes in vaginal ecology, and impaired immunity (<em><a href="https://www.cdc.gov/std/tg2015/references.htm#656">656</a>,<a href="https://www.cdc.gov/std/tg2015/references.htm#720">720,721</a></em>).</p>

<h5>Treatment</h5>

<p>Treatment reduces symptoms and signs of <em>T. vaginalis</em> infection and might reduce transmission. Likelihood of adverse outcomes in women with HIV is also reduced with <em>T. vaginalis</em> therapy.</p>

<div class="module-typeF">
<h5><em>Recommended Regimen for Women with HIV Infection</em></h5>

<ul class="list-block">
<li><strong>Metronidazole</strong> 500 mg orally twice daily for 7 days</li>
</ul>
</div>

<p>In women with HIV infection who receive a diagnosis of <em>T. vaginalis</em> infection, retesting is recommended within 3 months following initial treatment; NAAT is encouraged because of higher sensitivity of these tests. Data are insufficient to recommend routine screening, alternative treatment regimens of longer duration, or retesting in men.</p>



<p style=" text-align: right;"><a href="https://www.cdc.gov/std/tg2015/candidiasis.htm">Next</a></p>
             					            					            					            						</div>
            													        						                                                                                        						                                                                								<!-- Related Nav Area -->
								<div class="nav-related hidden-three hidden-four">
									



									



<div class="module-typeH">
<h3><a href="../default.htm">STDs Home Page</a></h3>

<ul class="list-block">
<li><a href="../treatment/default.htm">Treatment</a></li>
</ul>
</div>

<div class="module-typeH">
<h3>Follow STD</h3>

<ul class="list-block">
<li><a href="https://twitter.com/CDCSTD"><span class="sprite-32-twitter"><!-- marker --></span>STD on Twitter</a></li>

<li style=" text-align: left;"><a href="https://www.facebook.com/CDCSTD"><span class="sprite-32-facebook"><!-- marker --></span>STD on Facebook</a></li>
</ul>
</div>


								</div>
    							<!-- Persistent Content Area -->
    							<div id="content-secondary">
                                    



            						



    							</div><!-- /end #content-secondary -->
    						</div><!-- /end #contentArea -->
    					</div><!-- /end body -->	
					</div>
					<div class="row">
						<div class="span24 visible-one">
																											</div>
					</div>
					<div class="row">
						<div class="span24">
                            <div id="plugin-legend" class="pluginOff">
	<h5>File Formats Help:</h5><span><a href="../../Other/plugins/index.html">How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?</a></span>
	<ul>
		<li class="plugin-pdf"><a href="../../Other/plugins/index.html#pdf"><span class="sprite-16-pdf">Adobe PDF file</span></a></li>
		<li class="plugin-ppt"><a href="../../Other/plugins/index.html#ppt"><span class="sprite-16-ppt">Microsoft PowerPoint file</span></a></li>
		<li class="plugin-word"><a href="../../Other/plugins/index.html#doc"><span class="sprite-16-word">Microsoft Word file</span></a></li>
		<li class="plugin-excel"><a href="../../Other/plugins/index.html#xls"><span class="sprite-16-excel">Microsoft Excel file</span></a></li>
		<li class="plugin-wmv"><a href="../../Other/plugins/index.html#wmv"><span class="sprite-16-wmv">Audio/Video file</span></a></li>
		<li class="plugin-qt"><a href="../../Other/plugins/index.html#qt"><span class="sprite-16-qt">Apple Quicktime file</span></a></li>
		<li class="plugin-real"><a href="../../Other/plugins/index.html#ram"><span class="sprite-16-rp">RealPlayer file</span></a></li>
		<li class="plugin-text"><a href="../../Other/plugins/index.html#text"><span class="sprite-16-txt">Text file</span></a></li>
		<li class="plugin-zip"><a href="../../Other/plugins/index.html#zip"><span class="sprite-16-zip">Zip Archive file</span></a></li>
		<li class="plugin-sas"><a href="../../Other/plugins/index.html#sas"><span class="sprite-16-sas">SAS file</span></a></li>
		<li class="plugin-epub"><a href="../../Other/plugins/index.html#epub"><span class="sprite-16-ebook">ePub file</span></a></li>
		<li class="plugin-ris"><a href="../../Other/plugins/index.html#ris"><span class="sprite-16-ris">RIS file</span></a></li>
	</ul>
</div>
						</div>
					</div>
					<!-- date stamp -->
					<div id="datestamp" class="row" itemscope="itemscope" itemtype="http://schema.org/WebPage">
						<div class="span24">
    						<ul> 
            					            						<li class="last-reviewed">Page last reviewed: <span itemprop="lastReviewed">June 4, 2015</span></li>
            													            					            						<li class="last-updated">Page last updated: <span itemprop="dateModified">August 12, 2016</span></li>
            					        							<li class="content-source">Content source:
    									


<ul class="noindent"><li class="" itemprop="sourceOrganization" itemscope="itemscope" itemtype="http://schema.org/Organization"><a href="../dstdp.1.html" itemprop="url">Division of STD Prevention</a>, <a href="../../nchhstp.1.html" itemprop="url">National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention</a>, <a href="../../index.html" itemprop="url">Centers for Disease Control and Prevention</a></li></ul>

        							</li>
									



    						</ul>
						</div>
					</div>					
				</div><!-- /end #content -->
			</div><!-- /.container for content -->					
			<!-- footer -->
				<footer id="footer" class="cdcSlimFooter">
	
 <!-- include eng footerSubSocialMedia.html -->
<div class="socialMedia">
	<div class="container">
		<nav class="followcdc">
			<ul>
				<li><a href="../../Other/emailupdates.1.html"><span class="sprite-24-govd"></span><span class="tp-sr-only">Email</span></a></li>
				<li><a href="https://www.facebook.com/CDC" target="_blank"><span class="sprite-24-facebook"></span><span class="tp-sr-only">Recommend</span></a></li>
				<li><a href="https://twitter.com/CDCgov" target="_blank"><span class="sprite-24-twitter"></span><span class="tp-sr-only">Tweet</span></a></li>
				<li><a href="https://www.youtube.com/user/CDCstreamingHealth" target="_blank"><span class="sprite-24-youtube"></span><span class="tp-sr-only">YouTube</span></a></li>
				<li><a href="https://www.instagram.com/CDCgov/" target="_blank"><span class="sprite-24-instagram"></span><span class="tp-sr-only">Instagram</span></a></li>
			</ul>
		</nav>
		<nav class="cdcmedia">
			<ul>
				<li><a href="https://www2c.cdc.gov/podcasts"><span class="sprite-24-listen"></span><span class="tp-sr-only">Listen</span></a></li>
				<li><a href="../../cdctv.1.html"><span class="sprite-24-watch"></span><span class="tp-sr-only">Watch</span></a></li>
				<li><a href="https://www2c.cdc.gov/podcasts/rss.asp"><span class="sprite-24-rss"></span><span class="tp-sr-only">RSS</span></a></li>
			</ul>
		</nav>
	</div>
</div>
 <!-- /include eng footerSubSocialMedia.html -->

	<div class="container">
		<div class="cdcLinks">
			<div class="container">
				<ul>
					
<!-- include eng footerSubCdcLinks.html-->
<li>
	<nav>
		<h6 class="hidden-four hidden-three">ABOUT <span class="icon-plus visible-one pull-right"></span></h6>
		<ul class="hidden-one">
			<li><a href="../../about/default.htm">About CDC</a></li>
			<li><a href="https://jobs.cdc.gov">Jobs</a></li>
			<li><a href="../../funding.1.html">Funding</a></li>
		</ul>
	</nav>
</li>
<li>
	<nav>
		<h6 class="hidden-four hidden-three">LEGAL <span class="icon-plus visible-one pull-right"></span></h6>
		<ul class="hidden-one">
			<li><a href="../../Other/policies.html">Policies</a></li>
			<li><a href="../../Other/privacy.html">Privacy</a></li>
			<li><a href="../../od/foia.1.html">FOIA</a></li>
			<li><a href="../../eeo/nofearact/index.htm">No Fear Act</a></li>
			<li><a href="https://oig.hhs.gov" class="no-link">OIG</a></li>
		</ul>
	</nav>
</li>
<!--/ include eng footerSubCdcLinks.html-->

				</ul>
			</div>
		</div>
		<div class="cdcContact">
			<div class="container">
				<ul>
					<li class="local-contact">
						
 <!-- include eng footerSubGlobalContact1.html -->
<section>
	<address class="address" itemscope="itemscope" itemtype="https://schema.org/Organization">
		<span class="value" itemprop="address" itemscope="itemscope" itemtype="https://schema.org/PostalAddress">
			<span itemprop="streetAddress">1600 Clifton Road</span>
			<span itemprop="addressLocality">Atlanta</span>,
			<span itemprop="addressRegion">GA</span>
			<span itemprop="postalCode">30329-4027</span>
			<span itemprop="addressCountry">USA</span>
		</span><br />
		<span class="value" itemprop="telephone">800-CDC-INFO (800-232-4636)</span>,
		<span class="value" itemprop="telephone">TTY: 888-232-6348</span><br />
		<span class="value" itemprop="contactPoint" itemscope="itemscope" itemtype="https://schema.org/ContactPoint">
			<span itemprop="url"><a href="https://wwwn.cdc.gov/dcs/RequestForm.aspx" class=" default no-link">Email CDC-INFO</a></span>
		</span>
	</address>
</section>
 <!-- /include eng footerSubGlobalContact1.html -->

					</li>
					<li class="contact">
						
 <!-- include eng footerSubGlobalContact2.html -->
<section>
	<address class="address" itemscope="itemscope" itemtype="https://schema.org/Organization">
		<span class="value" itemprop="contactPoint" itemscope="itemscope" itemtype="https://schema.org/ContactPoint">
			<span itemprop="url"><a href="https://www.hhs.gov" class="no-link">U.S. Department of Health & Human Services</a></span>
		</span><br />
        <span class="value" itemprop="contactPoint" itemscope="itemscope" itemtype="https://schema.org/ContactPoint">
        	<span itemprop="url"><a href="https://www.hhs.gov/open" class="no-link">HHS/Open</a></span>
        </span><br />
        <span class="value" itemprop="contactPoint" itemscope="itemscope" itemtype="https://schema.org/ContactPoint">
			<span itemprop="url"><a href="https://www.usa.gov/" class="no-link">USA.gov</a></span>
		</span>
	</address>
</section>
 <!-- /include eng footerSubGlobalContact2.html -->

					</li>
				</ul>
			</div>
		</div>
	</div>
</footer>			<!-- /#footer -->
			<div id="totop" class="off visible-one">Top</div>
        </div>
		<script>page_timing.libs_start = Date.now();</script><script src="../../TemplatePackage/3.0/js/libs.min.js@3.2.1.7"></script><script>page_timing.libs_end = Date.now();page_timing.core_start = Date.now();</script><script src="../../TemplatePackage/3.0/js/core.min.js@3.2.1.7"></script><script>page_timing.core_end = Date.now();</script><!-- Start Site Settings Overrides -->
<script>
CDC.Constants.set("flexSliderVideoDomains", ['youtube.com','ytimg.com','vimeocdn.com'], 'es');
	CDC.Global.settings.includeCDCInBreadCrumbBar=false;
</script>
<!-- End Site Settings Overrides --><script>page_timing.app_start = Date.now();</script><script src="../../TemplatePackage/3.0/js/app.min.js@3.2.1.7"></script><script>page_timing.app_end = Date.now();</script>		
		        			<!-- Begin Survey scripts -->
<script src="../../JScript/foresee/foresee-trigger.js"></script>
<script src="../../JScript/foresee-variables.js"></script>
<!-- End Survey scripts -->
			
            <script>if (typeof page_timing !== 'undefined') { page_timing.metrics_start = Date.now(); }</script>
<!-- xxxxxxxxxxxxxxxxxx METRICS code begins here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->
<div id="metrics">

<!-- Begin Google DAP inclusion -->
<script type="text/javascript" id="_fed_an_ua_tag" src="../../JScript/metrics/google/Universal-Federated-Analytics-Min.js@agency=HHS&amp;subagency=CDC"></script>
<!-- End Google DAP inclusion -->

<!-- Begin Template Package Custom Interactions -->
<script type="text/javascript" src="../../JScript/metrics/rd_custom_interactions.js"></script>
<!-- End Template Package Custom Interactions -->

<!-- SiteCatalyst code version: H.21. -->
<script src="../../JScript/metrics/topic_levels.js"></script>
<script src="../../JScript/metrics/s_code_v21_cdcgov.js"></script>
<script>

	enquire.register(CDC.Global.selectors.vp1, function() {
		s.prop49 = 1;
	});
	enquire.register(CDC.Global.selectors.vp2, function() {
		s.prop49 = 2;
	});
	enquire.register(CDC.Global.selectors.vp3, function() {
		s.prop49 = 3;
	});
	enquire.register(CDC.Global.selectors.vp4, function() {
		s.prop49 = 4;
	});

            
            


    s.pageName=document.title
    s.channel="STD"
    siteCatalyst.setLevel1("NCHHSTP"); 
    siteCatalyst.setLevel2("DSTDP"); 
    siteCatalyst.setLevel3("Treatment"); 
        

            
                        
            s.prop2=window.location.href;
s.prop26=document.title;
s.prop30=document.title;
s.prop31=window.location.href;
s.prop46=window.location.href;
s.server=window.location.hostname;

// Update the level variables here.
updateVariables(s);

/************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/
var s_code=s.t();



if(s_code) {
	document.write(s_code);
}



if (document.location.protocol) {


	var cookieManagment = {
		getUuid : function (strPrefix) {
			strPrefix = strPrefix || "";
			var d = new Date();
			var seconds = Math.round(d.getTime() / 1000);
			return strPrefix + Math.floor((1 + Math.random()) * 0x10000).toString(16).substring(1) + "-" + seconds.toString();
		},
		setCookie : function (cname, cvalue, exdays, domain) {
			domain = domain || ".cdc.gov";
			var d = new Date();
			d.setTime(d.getTime() + (exdays*24*60*60*1000));
			var expires = "expires="+ d.toUTCString();
			document.cookie = cname + "=" + cvalue + ";" + expires + ";domain=" + domain + ";path=/";
		},
		getCookie : function (cname) {
			var name = cname + "=";
			var ca = document.cookie.split(';');
			var i = ca.length;
			while (i --) {
				var c = ca[i];
				while (c.charAt(0)==' ') {
					c = c.substring(1);
				}
				if (c.indexOf(name) == 0) {
					return c.substring(name.length,c.length);
				}
			}
			return "";
		},
		init : function () {



			var currCookieVal = cookieManagment.getCookie('cdc_s_vi');

			if (!currCookieVal.length || currCookieVal.indexOf('[CS]v1') != -1) {
				var newCookieVal = cookieManagment.getUuid('[CS]v2') + "-" + cookieManagment.getUuid('');
				cookieManagment.setCookie("cdc_s_vi", newCookieVal, 7);
				return newCookieVal;
			}
			return currCookieVal;
		}
	};


	var cdcSessionID = cookieManagment.init();

	s3 = s_gi("cdcgovvistorid");

	var sKey, override = {
		fun: "cdcgovvistorid",
		trackingServer: "cdc.112.2o7.net"
	};

	s3.visitorID = cdcSessionID;

	for (sKey in s) {
		if (s.hasOwnProperty(sKey)) {
			if (override.hasOwnProperty(sKey)) {
				s3[sKey] = override[sKey];

			} else {

			}
		}
	}
	updateVariables(s3);


	var s_code_uvid = s3.t();
	if(s_code_uvid) {
		document.write(s_code_uvid);
	}
}




</script>
<script type="text/javascript">
if(navigator.appVersion.indexOf('MSIE')>=0) { document.write(unescape('%3C')+'\!-'+'-'); }
</script>
<noscript><a href="http://www.omniture.com"><img src="https://smtrics.cdc.gov/b/ss/cdcgov/1/H.21--NS/01/H.21--NS/0" height="1" width="1" alt="Web Analytics" /></a></noscript><!--/DO NOT REMOVE/-->
<!-- End SiteCatalyst code version: H.21. -->
<!-- Begin Template Package DigitalGov Search Support -->
<script type="text/javascript" src="../../JScript/rd_search.js"></script>
<!-- End Template Package DigitalGov Search Support -->
</div>
<!-- xxxxxxxxxxxxxxxxxx METRICS code ends here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->
<script>if (typeof page_timing !== 'undefined') { page_timing.metrics_end = Date.now(); }</script>
				

<script>
<!--//
 $(document).ready(function () {
  var cdcLeftNav = new CDC.LeftNav("nav-primary");
  cdcLeftNav.render();
 });
//-->
</script>

    	



						    </body>
	</html>
